Lunnan Qi
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 10, 2025
Hyper-Relapse Disease is a Special Pattern of Relapse of Hepatocellular Carcinoma After Curative Hepatectomy: A Retrospective Cohort Study.Zi-Liang Yang, Yi-Xiang Gan, Jing-Xuan Xu
|Jan 27, 2025
Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with 'progression/hyper-progression' recurrence.Jing-Xuan Xu, Yue-Xiang Su, Yuan-Yuan Chen
|Jun 20, 2023
Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors.Hao-Wen Wei, Shui-Ling Qin, Jing-Xuan Xu
|Feb 07, 2023
Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization.Jing-Xuan Xu, Shui-Lin Qin, Hao-Wen Wei
|Jan 23, 2023
High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells.Zhan Lu, Yiyue Huang, Juntao Huang
|Jul 26, 2022
Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy.Hang-Hang Ni, Xi-Hua Yang, Cheng-Lei Yang
Pageof 2
